You are here

Tüberkulum Sella Meningiomalı Gebe Kadında Görme Kaybı

Visual Deterioration in A Pregnant Woman With Tuberculum Sellae Meningioma

Journal Name:

Publication Year:

Abstract (2. Language): 
The incidence of meningioma in pregnant women is lower than non-pregnant women of the same age. However, symptoms may worsen during pregnancy. A 34-years old woman in her fourth pregnancy presented at 10 weeks of gestation with a 4 weeks history of progressive visual loss in her left eye. MRI revealed mass lesion that filled the suprasellar cistern and extended into the sella with dural tail. The patient underwent operation and a tuberculum sellae meningioma was removed totally. The immunohistochemical analysis showed positive staining for progesterone receptors in 80% of meningioma cells. The rapid growth of the mass that stains positive for progesterone receptors and the enlargement of the pituitary gland because of the hormonal changes during pregnancy in cases with tuberculum sellae meningioma can cause sudden visual loss.
Abstract (Original Language): 
Gebe kadınlarda meningioma görülme insidansı,normal kadın popülasyonuna göre daha düşüktür fakat gebelikte meningiomaya bağlı semptomlar artabilirler. 34 yaşında bayan hasta gebeliğinin onuncu haftasında; 4 haftadır sol gözünde başlayan görme kaybıyla başvurdu. Kranial MRI görüntülerinde; suprasellar sisterna ve sella içini doldurmuş, dural kuyruğu olan kitle lezyonu mevcuttu.Hasta operasyona alınarak, tuberkulum sella meningioması total çıkartıldı. İmmünohistokimyasal analizinde; meningioma hücrelerinin % 80 olarak progesteron reseptö- rü taşıdığı gösterildi. Tuberkulum sella meningiomalı gebe kadınlarda; pozitif progesteron reseptörüne ve hipofiz bezinin büyümesine bağlı olarak ani görme kaybı gerçekleşebilmektedir.
117-119

REFERENCES

References: 

1. Goldberg M, Rappaport ZH. Neurosurgical, obstetric and
endocrine aspects of meningioma during pregnancy. Israel J
Med Sci. 1987;23:825–8.
2. Kanaan I, Jallu A, Kanaan H. Management strategy for
meningioma in pregnancy: a clinical study. Skull Base.
2003;13: 197–203.
3. Haas JF, Jaenisch W, Staneczek W. Newly diagnosed primary
intracranial neoplasms in pregnant women: a population based
assessment. J Neurol Neurosurg Psychiatry. 1986; 49: 874–80.
4. Ebner FH, Bornemann A, Wilhelm H, Ernemann U, Honegger
J Tuberculum sellae meningioma symptomatic during
pregnancy: pathophysiological considerations Acta Neurochir
(Wien). 2008;150: 189–93.
5. Weynand R, MacCarty C,Wilson R The effect of pregnancy on
intracranial meningiomas occurring about the optic chiasm.
Surg Clin North Am. 1951; 31: 1225–33.
6. Roelvink NC, Kamphorst W, August H, van Alphen M, Rao
BR. Literature statistics do not support a growth stimulating role for female sex steroid hormones in haemangiomas and
meningiomas. J Neurooncol. 1991; 11: 243–53.
7. Olivi A, Rhines LD, Dimeco F (2004) Brain tumors during
pregnancy. Chapter 45 in Youman’s Neurological Surgery, pp
867–76.
8. Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67
proliferation antigen in meningiomas. Experience in 600 cases.
Acta Neurochir (Wien). 2004; 146: 37–44.
9. Perry A, Dehner LP. Meningeal tumors of childhood and
infancy. An update and literature review. Brain Pathol
2003;13:386-408.
10. Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE,
Villarreal JZ. Pituitary gland growth during normal pregnancy:
an in vivo study using magnetic resonance imaging. Am J Med.
1988;85:217-20.

Thank you for copying data from http://www.arastirmax.com